Feature INmune Bio harnessing innate immune system against cancer, neurodegenerative diseases INmune Bio (NASDAQ:INMB) is developing new therapies that modulate the innate immune system, the body’s first line of defense against pathogens, to treat cancer and neuroinflammation that lead to neurodegenerative... September 24, 2019